Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,621,588
+$4,034,882 QoQ
Shares Held
441,829
-0.5% QoQ
Ownership
0.347%
of shares outstanding
% of Portfolio
2.76%
of 13F equity value
Holder Rank
#38
of 228 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. RCUS ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
562,630 | $105,369,346 | |
| 2 | NKTR |
Nektar Therapeutics
|
318,380 | $22,226,107 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
739,014 | $19,007,440 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
497,240 | $18,532,134 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
250,772 | $15,136,597 | |
| 6 | CYTK |
Cytokinetics Inc
|
171,998 | $14,652,509 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
This page
|
441,829 | $13,621,588 | |
| 8 | ASND |
Ascendis Pharma A/S
|
48,469 | $12,927,651 |
All Filings in RCUS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,621,588 | 441,829 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,586,706 | 443,829 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,278,570 | 431,329 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,535,713 | 627,626 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,108,875 | 627,626 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,907,239 | 625,126 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,785,291 | 254,217 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,925,202 | 256,717 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,856,494 | 253,217 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,374,816 | 231,717 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,444,894 | 232,717 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,997,770 | 222,717 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,584,312 | 225,717 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,195,958 | 175,217 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,941,047 | 142,217 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,675,236 | 178,717 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,756,748 | 187,717 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,583,048 | 145,217 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,743,084 | 117,200 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,313,419 | 123,700 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,286,962 | 119,700 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,617,408 | 57,600 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,287,616 | 49,600 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,235,794 | 72,100 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,783,754 | 72,100 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $385,836 | 27,798 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||